Drug intelligence / Profile preview

Yikang Buyuan Granule

Development stage
Unknown
Lead developer
Beijing Hospital of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Yikang Buyuan Granule is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Chinese Medicine Hospital affiliated to Capital Medical University. It is specifically indicated for the treatment of chronic fatigue syndrome (CFS), particularly when characterized by the TCM pattern of 'qi deficiency and blood stasis syndrome'. The preparation is designed to replenish vital energy (qi) and promote blood circulation to alleviate persistent fatigue and improve overall quality of life. It has been evaluated in clinical settings in China, including phase 4 observational case series, where its efficacy was assessed using standardized fatigue severity scales and quality-of-life questionnaires.

Brand names
Yikang Buyuan Granule
Other names
Yikang Buyuan Keli益康补元颗粒

Beyond the preview

Go deeper on Yikang Buyuan Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yikang Buyuan Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call